12 NOVEMBER 2021 |
||||||||||
ADULT HEMATOLOGY PROGRAM | ||||||||||
07.40-08.40 |
ORAL PRESENTATION SESSIONS 2 |
Oktay Bilgir, İlhami Kiki, Alpay Yeşilaltay |
||||||||
SESSION 11 - New Thinking on Glanzmann Thrombasthenia: When Function Dominates and COAGULATION PROBLEMS |
CHAIRS: Drew Provan - Bülent Zülfikar | |||||||||
08.40-09.00 |
Hemophilia |
Margareth C. Ozelo |
||||||||
09.00-09.20 |
New Thinking on ITP |
Drew Provan |
||||||||
09.20-09.40 |
New Thinking on Glanzmann Thrombasthenia: When Function Dominates |
Hanan Hamed |
||||||||
09.40-10.00 |
Coumadin and New Oral Anticoagulants: Which and When |
Özgür Mehtap |
||||||||
10.00-10.20 |
GENERAL DISCUSSION Chair: Selami Koçak Toprak | |||||||||
10.20-10.40 | COFFEE BREAK |
|||||||||
SESSION 12 - CHRONIC LYMPHOCYTIC LEUKEMIAS AND INDOLENT LYMPHOMAS |
CHAIRS: Robin Foà - Berksoy Şahin | |||||||||
10.40-11.00 | Current Therapy of CLL |
Antonio Cuneo |
||||||||
11.00-11.20 | Indolent Lymphomas |
Carmino de Souza |
||||||||
11.20-11.40 | New Drugs for Low Grade Lymphoproliferative Disease |
Argiris Simeonidis |
||||||||
11.40-12.00 | Can We Cure CLL? |
Robin Foà |
||||||||
12.00-12.20 | GENERAL DISCUSSION Chair: Mehmet Turgut | |||||||||
12.20-13.20 | LUNCH BREAK |
|||||||||
13.20-14.00 |
SATELLITE SYMPOSIUM-The Rising Role of Venetoclax in the Era of Novel CLL Therapies |
CHAIRS: Burhan Ferhanoğlu - SPEAKER: Mehmet Ali Özcan | ||||||||
SESSION 13 - SPECIAL TOPICS FOR LYMPHOMAS |
CHAIRS: Anna Maria Sureda Balari - Burhan Ferhanoğlu | |||||||||
14.00-14.20 |
Treatment of Relapsed/Refractory Diffuse large B Cell Lymphoma | Burhan Ferhanoğlu |
||||||||
14.20-14.40 |
Treatment of R/R Hodgkin Lymphoma |
Anna Maria Sureda Balari |
||||||||
14.40-15:00 |
Response adapted maintenance therapy in FL:Lessons
from the FOLL12 Trial |
Massimo Federico |
||||||||
15.00-15.20 |
Treatment of R/R Follicular Lymphoma |
Stefano Luminari |
||||||||
15.20-15.40 |
GENERAL DISCUSSION Chair: Olga Meltem Akay | |||||||||
15.40-16.00 | COFFEE BREAK |
|||||||||
SESSION 14 - TRANSPLANTATION |
CHAIRS: Arnon Nagler - Seçkin Çağırgan | |||||||||
16.00-16.20 |
Haplo vs MUD transpplant |
Arnon Nagler |
||||||||
16.20-16.40 |
GVHD Treatment |
Elif Birtaş Ateşoğlu |
||||||||
16.40-17.00 |
Car-T Cell |
Francesco Saglio |
||||||||
17.00-17.20 |
Reduced Intensity Conditioning Treatment: Current View |
Daniela Cilloni |
||||||||
17.20-17.40 |
GENERAL DISCUSSION Chair: Hakan Göker | |||||||||
17.40-18.20 |
SATELLITE SYMPOSIUM-Immunotherapies and Increased Opdivo Experiences in Turkey in the Treatment of R / R Hodgkin Lymphoma |
CHAIRS: Birol Güvenç - Mustafa Çetiner - SPEAKER: Mehmet Ali Özcan |
||||||||
SESSION 15 -
ACUTE LYMPHOBLASTIC LEUKEMIA |
CHAIRS:Dieter Hoelzer - Gülsüm Özet | |||||||||
18.20-18.40 |
European Vision of ALL Treatment |
Dieter Hoelzer (Debate) |
||||||||
18.40-19.00 |
American Vision of ALL Treatment |
Hagop Kantarjian (Debate) |
||||||||
19.00-19.20 |
T-Cell ALL |
Ali Bazarbachi |
||||||||
19.20-19.40 |
Ph-Positive ALL |
Robin Foà |
||||||||
19.40-20.00 |
GENERAL DISCUSSION Chair:Sema Anak | |||||||||
13 NOVEMBER 2021 |
||
ADULT HEMATOLOGY PROGRAM | ||
07.40-08.40 |
ORAL PRESENTATION SESSIONS 3 |
Demet Çekdemir, Güven Çetin, Vahap Okan |
SESSION 16- ACUTE MYELOID LEUKEMIA |
CHAIRS: Charles Schiffer - Erdal Kurtoğlu | |
08.40-09.00 |
Essential Molecular Characterisation of AML Patients |
Mehmet Yılmaz |
09.00-09.20 |
How I Treat AML |
Charles Schiffer |
09.20-09.40 |
Targeted Therapy in AML Treatment |
Giovanni Martinelli |
09.40-10.00 |
Importance of Mınımal Residual Diesease Detection in
AML Treatment |
Claudio Cerhcione |
10.00-10.20 |
GENERAL DISCUSSION Chair: Düzgün Özatlı | |
10.20-10.40 | COFFEE BREAK |
|
Session 17 : Ph-NEGATIVE AND POSITIVE MPNs |
CHAIRS: Tariq Mughal - Ayşe Tülin Tuğlular | |
10.40-11.00 |
How I Treat Policytemia Vera |
Francesco Passamonti |
11.00-11.20 |
How I Treat Myelofibrosis |
Tariq Mughal |
11.20-11.40 |
When Standard TKIs Do Not Suffice |
Pia Ranani |
11.40-12.00 |
How I Treat Essential Thrombocythemia |
Güray Saydam |
12.00-12.20 |
GENERAL DISCUSSION Chair: Ömür Gökmen Sevindik | |
12.20-13.20 |
LUNCH BREAK |
|
13.20-14.00 |
BREAK |
|
Session 18: MDS |
CHAIRS: Rajko Kusec - Mustafa Nuri Yenerel | |
14.00-14.20 |
MDS Diagnosis - Often Easy - Occasionally Challenging |
Moshe Mittelman |
14.20-14.40 |
How I Treat MDS |
Guillermo Garcia Manero |
14.40-15:00 |
New Drugs for MDS |
Elias Jabbour |
15.00-15.20 |
Luspatercept in MDS |
Mustafa Çetiner |
15.20-15.40 |
GENERAL DISCUSSION Chair: Ant Uzay | |
15.40-16.00 |
COFFEE BREAK |
|
Session 19: NEW
BIOLOGICAL INSIGHTS INTO THE HEMATOLOGICAL DISEASES |
CHAIRS: Vera Donnenberg - Nilgün Sayınalp | |
16.00-16.15 |
Evolution of the Pleural Secretome Associated with
Pleural Metastasis. |
Albert Donnenberg |
16.15-16.30 |
Intrapleural Therapy to Drive Systemic Anti-Tumor
Immunity |
Vera Donnenberg |
16.30-16.45 |
The Promising Role of the HDHODH Inhibitors in the
Therapy of Acute and Chronic Myeloid Leukemias |
Mohammad Houshmand |
16.45-17.00 |
Congenital Erythrocyte Defects of the Paediatric Age |
Achilles Iolascon |
17.00-17.15 |
Invasive Fungal Infections in Heamatological Patients in COVID-19 Pandemic |
Ömrüm Uzun |
17.15-17.30 |
GENERAL DISCUSSION Chair: Pervin Topcuoğlu | |
17.30 |
CLOSING |
|